CNS Pharmaceuticals, Inc. Common Stock
Symbol: CNSP (NASDAQ)
9.05
▼ (-1.10%) -0.101
Company Description:
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
Key Stats
- Today's Open: $8.667
- Today's High: $9.2
- Today's Low: $8.667
- Today's Volume: 8.99K
- Yesterday Close: $9.15
- Yesterday High: $9.3
- Yesterday Low: $8.91
- Yesterday Volume: 12.21K
- Last Min Volume: 0
- Last Min High: $9.049
- Last Min Low: $8.992
- Last Min VWAP: $0
Company Profile
- Name: CNS Pharmaceuticals, Inc. Common Stock
- Website: https://www.cnspharma.com
- Listed Date: 2019-11-08
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001729427
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.26M
- Round Lot: 100
- Outstanding Shares: 574.58K
- Asset Type: CS
RECENT FILINGS FOR CNSP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-10 | PRE 14A | View |
| 2025-09-19 | 424B5 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-22 | 8-K | View |
| 2025-07-15 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-14 | 424B4 | View |
| 2025-05-13 | EFFECT | View |
| 2025-05-12 | CORRESP | View |
| 2025-05-12 | CORRESP | View |
| 2025-05-12 | S-1/A | View |
| 2025-04-30 | 10-K/A | View |
| 2025-04-17 | CORRESP | View |
| 2025-04-17 | CORRESP | View |
| 2025-04-14 | CORRESP | View |
| 2025-04-14 | CORRESP | View |
| 2025-04-14 | S-1 | View |
| 2025-04-11 | UPLOAD | View |
Latest News on CNSP